SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-21-058954
Filing Date
2021-11-15
Accepted
2021-11-15 07:29:15
Documents
53
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 ea150538-6k_gamida.htm   iXBRL 6-K 18983
2 ea150538ex99-1.htm EX-99.1 223564
3 ea150538ex99-2.htm   iXBRL EX-99.2 629684
9 GRAPHIC ex99-1_001.jpg GRAPHIC 2597
  Complete submission text file 0001213900-21-058954.txt   3443443

Data Files

Seq Description Document Type Size
4 XBRL DEFINITION FILE gmda-20210930_def.xml EX-101.DEF 150175
5 XBRL LABEL FILE gmda-20210930_lab.xml EX-101.LAB 324833
6 XBRL PRESENTATION FILE gmda-20210930_pre.xml EX-101.PRE 160423
7 XBRL SCHEMA FILE gmda-20210930.xsd EX-101.SCH 52520
8 XBRL CALCULATION FILE gmda-20210930_cal.xml EX-101.CAL 35845
10 EXTRACTED XBRL INSTANCE DOCUMENT ea150538-6k_gamida_htm.xml XML 437925
Mailing Address 5 NAHUM HAFZADI STREET JERUSALEM L3 95484
Business Address 5 NAHUM HAFZADI STREET JERUSALEM L3 95484 97226595666
Gamida Cell Ltd. (Filer) CIK: 0001600847 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38716 | Film No.: 211406320
SIC: 2836 Biological Products, (No Diagnostic Substances)